Global Biotechnology Industry Profile & Value Chain Analysis
Global Biotechnology Industry Profile & Value Chain Analysis
SUMMARY
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
The value chain analysis reveals the business activities which comprise the global biotechnology industry value chain. All key stages are highlighted, along with examples of companies active, and assessments of the burning issues for every stage of the value chain. Key value chain stages analyzed include raw materials, chemicals, biotechnology producers, and B2B end users.
SYNOPSIS
Essential resource for top-line data and analysis covering the global biotechnology industry. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
KEY HIGHLIGHTS
SUMMARY
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
The value chain analysis reveals the business activities which comprise the global biotechnology industry value chain. All key stages are highlighted, along with examples of companies active, and assessments of the burning issues for every stage of the value chain. Key value chain stages analyzed include raw materials, chemicals, biotechnology producers, and B2B end users.
SYNOPSIS
Essential resource for top-line data and analysis covering the global biotechnology industry. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
KEY HIGHLIGHTS
- The biotechnology industry consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The global biotechnology industry had total revenues of $353.9bn in 2016, representing a compound annual growth rate (CAGR) of 8.8% between 2012 and 2016.
- The medical/healthcare segment was the industry's most lucrative in 2016, with total revenues of $202.3bn, equivalent to 57.2% of the industry's overall value.
- Globally, the biotechnology industry is driven by the US and Asia-Pacific which make up 46.5% and 24.9% respectively.
- Biotechnology’s wide applications mean it has various B2B End-users. The main verticals are healthcare, agriculture, consumer products and industrial manufacturing
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology industry
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global biotechnology industry
- Leading company profiles reveal details of key biotechnology industry players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global biotechnology industry with five year forecasts
- Quickly and easily identify the key stages and sub-stages of the global biotechnology industry value chain
- See examples of companies active at each stage of the global biotechnology industry value chain
- Examine trends and burning issues impacting the global biotechnology industry value chain
- What was the size of the global biotechnology industry by value in 2016?
- What will be the size of the global biotechnology industry in 2021?
- What factors are affecting the strength of competition in the global biotechnology industry?
- How has the market performed over the last five years?
- What are the main segments that make up the global biotechnology industry?
- What are the key stages of the global biotechnology industry value chain?
Executive Summary
Value chain analysis
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Value Chain Analysis
Biotechnology industry complete value chain overview
Raw Materials
Suppliers
Biotechnology Producers
B2B End-users
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Amgen, Inc.
Covance Inc.
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
Value chain analysis
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Value Chain Analysis
Biotechnology industry complete value chain overview
Raw Materials
Suppliers
Biotechnology Producers
B2B End-users
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Amgen, Inc.
Covance Inc.
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
LIST OF TABLES
Table 1: Global biotechnology industry value: $ billion, 2012-16
Table 2: Global biotechnology industry category segmentation: $ billion, 2016
Table 3: Global biotechnology industry geography segmentation: $ billion, 2016
Table 4: Global biotechnology industry value forecast: $ billion, 2016-21
Table 5: Amgen, Inc.: key facts
Table 6: Amgen, Inc.: key financials ($)
Table 7: Amgen, Inc.: key financial ratios
Table 8: Covance Inc.: key facts
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: key financials ($)
Table 11: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 12: F. Hoffmann-La Roche Ltd: key financial ratios
Table 13: Merck & Co., Inc.: key facts
Table 14: Merck & Co., Inc.: key financials ($)
Table 15: Merck & Co., Inc.: key financial ratios
Table 1: Global biotechnology industry value: $ billion, 2012-16
Table 2: Global biotechnology industry category segmentation: $ billion, 2016
Table 3: Global biotechnology industry geography segmentation: $ billion, 2016
Table 4: Global biotechnology industry value forecast: $ billion, 2016-21
Table 5: Amgen, Inc.: key facts
Table 6: Amgen, Inc.: key financials ($)
Table 7: Amgen, Inc.: key financial ratios
Table 8: Covance Inc.: key facts
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: key financials ($)
Table 11: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 12: F. Hoffmann-La Roche Ltd: key financial ratios
Table 13: Merck & Co., Inc.: key facts
Table 14: Merck & Co., Inc.: key financials ($)
Table 15: Merck & Co., Inc.: key financial ratios
LIST OF FIGURES
Figure 1: Biotechnology industry complete value chain overview
Figure 2: Biotechnology industry complete value chain with active companies
Figure 3: Raw Materials - Overview
Figure 4: Suppliers - Overview
Figure 5: Biotechnology Producers - Overview
Figure 6: B2B End-users - Overview
Figure 7: Global biotechnology industry value: $ billion, 2012-16
Figure 8: Global biotechnology industry category segmentation: % share, by value, 2016
Figure 9: Global biotechnology industry geography segmentation: % share, by value, 2016
Figure 10: Global biotechnology industry value forecast: $ billion, 2016-21
Figure 11: Forces driving competition in the global biotechnology industry, 2016
Figure 12: Drivers of buyer power in the global biotechnology industry, 2016
Figure 13: Drivers of supplier power in the global biotechnology industry, 2016
Figure 14: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2016
Figure 15: Factors influencing the threat of substitutes in the global biotechnology industry, 2016
Figure 16: Drivers of degree of rivalry in the global biotechnology industry, 2016
Figure 17: Amgen, Inc.: revenues & profitability
Figure 18: Amgen, Inc.: assets & liabilities
Figure 19: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 20: F. Hoffmann-La Roche Ltd: assets & liabilities
Figure 21: Merck & Co., Inc.: revenues & profitability
Figure 22: Merck & Co., Inc.: assets & liabilities
Figure 1: Biotechnology industry complete value chain overview
Figure 2: Biotechnology industry complete value chain with active companies
Figure 3: Raw Materials - Overview
Figure 4: Suppliers - Overview
Figure 5: Biotechnology Producers - Overview
Figure 6: B2B End-users - Overview
Figure 7: Global biotechnology industry value: $ billion, 2012-16
Figure 8: Global biotechnology industry category segmentation: % share, by value, 2016
Figure 9: Global biotechnology industry geography segmentation: % share, by value, 2016
Figure 10: Global biotechnology industry value forecast: $ billion, 2016-21
Figure 11: Forces driving competition in the global biotechnology industry, 2016
Figure 12: Drivers of buyer power in the global biotechnology industry, 2016
Figure 13: Drivers of supplier power in the global biotechnology industry, 2016
Figure 14: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2016
Figure 15: Factors influencing the threat of substitutes in the global biotechnology industry, 2016
Figure 16: Drivers of degree of rivalry in the global biotechnology industry, 2016
Figure 17: Amgen, Inc.: revenues & profitability
Figure 18: Amgen, Inc.: assets & liabilities
Figure 19: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 20: F. Hoffmann-La Roche Ltd: assets & liabilities
Figure 21: Merck & Co., Inc.: revenues & profitability
Figure 22: Merck & Co., Inc.: assets & liabilities
